C-terminal mechano growth factor protects dopamine neurons: a novel peptide that induces heme oxygenase-1.
Quesada. Arnulfo A; Micevych. Paul P; Handforth. Adrian A
Key Findings
- MGF24 (24‑amino‑acid fragment) increases heme oxygenase‑1 (HO‑1) levels
- MGF24 shields dopamine neurons from three common Parkinson’s‑related toxins in cell culture
- In rats with a Parkinson‑like lesion, MGF24 reduces motor deficits and neuron loss, acting independently of the IGF‑1 receptor
Practical Outcomes
- At this point the data are not ready for personal dosing or protocols, but they highlight that tiny IGF‑1‑derived peptides might one day be used for neuro‑protection. Biohackers should watch for follow‑up studies and clinical trials before considering supplementation, and remain cautious about safety and dosing until human data emerge.
Summary
A short piece of the IGF‑1 related peptide called MGF24 was shown in lab cells and rats to protect dopamine‑producing brain cells from damage by boosting a protective protein called HO‑1. The protection worked even when the usual IGF‑1 pathway was blocked, suggesting a new way the peptide helps neurons survive. However, the work is still early‑stage and has only been tested in animals, not people.
Abstract
To assess potential efficacy of mechano growth factor (MGF) for chronic neurodegenerative disorders, we studied whether MGF protects dopamine (DA) neurons subjected to neurotoxic stress. We show that a short 24-amino acid C-terminal peptide of MGF (MGF24) upregulates heme oxygenase-1 (HO-1) expression and protects SH-SY5Y cells against apoptosis and cell loss induced by three DA cell-specific neurotoxins: 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenylpyridinium (MPP(+)), and rotenone. MGF24 maintains the mitochondrial membrane potential and blocks the release of mitochondrial apoptotic-inducing factor into the cytoplasm induced by 6-OHDA, MPP(+), and rotenone. Chemical inhibition of HO-1 with zinc protoporphyrin-IX prevents neuroprotection by MGF24 against the three neurotoxins. MGF24 does not activate Akt signaling nor does Akt inhibition block MGF24 protection of SH-SY5Y cells. In 6-OHDA-lesioned rats, central or peripheral MGF24 administration protects against the development of contralateral forelimb under-utilization, reduces ipsilateral nigral DA cell body loss, and attenuates tyrosine hydroxylase fiber loss in the ipsilateral striatum, independent of IGF-1 receptor activation. Peripheral MGF24 administration upregulates HO-1 expression in striatal and midbrain tissue. This report is the first to demonstrate that a small peptide, MGF24, upregulates HO-1, an important cell defense mediator, and protects DA cells, suggesting new strategies for neuroprotection in Parkinson's disease.
Study Information
pubmed
2009
2009-09-06T00:00:00.000Z
10.1016/j.expneurol.2009.08.029
38
51